Zimmer Biomet Holdings (ZBH) Short-Term Debt repayments (2018 - 2023)

Zimmer Biomet Holdings (ZBH) recorded quarterly Short-Term Debt repayments of $305.0 million in Q4 2023, up 175.31% quarter-over-quarter from -$405.0 million in Q3 2023.

Zimmer Biomet Holdings (ZBH) Short-Term Debt repayments (2018 - 2023) Analysis & Trends

Zimmer Biomet Holdings' Short-Term Debt repayments history runs 2 years deep, the most recent figure standing at $305.0 million for Q4 2023.

  • In Q4 2023, Short-Term Debt repayments changed N/A year-over-year to $305.0 million; the TTM figure through Dec 2024 stood at $165.0 million (down 49.23% YoY), while the FY2024 annual figure was $50.0 million, down 84.62% from the prior year.
  • Short-Term Debt repayments was $305.0 million for Q4 2023 at Zimmer Biomet Holdings, up from -$405.0 million in the prior quarter.
  • In the past five years, Short-Term Debt repayments ranged from a high of $305.0 million in Q4 2023 to a low of -$405.0 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt repayments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 259.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2023 305.00 Mn
Dec 31, 2023 305.00 Mn
Sep 30, 2023 -405.00 Mn
Sep 30, 2023 -405.00 Mn
Jun 30, 2023 265.00 Mn
Jun 30, 2023 265.00 Mn
Mar 31, 2023 160.00 Mn
Mar 31, 2023 160.00 Mn
Sep 30, 2018 25.00 Mn
Sep 30, 2018 25.00 Mn